Showing results (81-90 of 106) with videos related to
Sort By:
Pageof 11
Bone Marrow Transplantation|July 3, 2003
Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftmentT Hahn, U Bunworasate, M C George, et al.Bone Marrow Transplantation|January 25, 2005
A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's diseaseT Hahn, M Benekli, C Wong, et al.Bone Marrow Transplantation|December 11, 2012
Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantationN S Majhail, J D Rizzo, T Hahn, et al.Bone Marrow Transplantation|April 19, 2016
Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot studyE M Denzen, V Thao, T Hahn, et al.Bone Marrow Transplantation|July 5, 2001
Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and reviewN I Khushalani, F G Bakri, D Wentling, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 26, 1999
Thiotepa-associated cardiomyopathy during blood or marrow transplantation: association with the female sex and cardiac risk factorsA Alidina, D Lawrence, L A Ford, et al.Bone Marrow Transplantation|April 25, 2001
Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparinM Simon, T Hahn, L A Ford, et al.Bone Marrow Transplantation|November 26, 2013
Second transplants for multiple myeloma relapsing after a previous autotransplant-reduced-intensity allogeneic vs autologous transplantationC O Freytes, D H Vesole, J LeRademacher, et al.Bone Marrow Transplantation|August 6, 2003
Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patientsT Hahn, C Rondeau, A Shaukat, et al.The American Journal of Medicine|March 1, 1996
Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histologyK W van Besien, R C Mehra, S A Giralt, et al.Pageof 11